

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 4.38536411 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.38536411 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.38536411 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.38536411 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 4.38536411 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.38536411 |
| 7 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.30412970 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.16925889 |
| 9 | response to peptidoglycan (GO:0032494) | 4.09239628 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.07524008 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.90380773 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 3.63121497 |
| 13 | detection of other organism (GO:0098543) | 3.57599976 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.57348140 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57348140 |
| 16 | cellular extravasation (GO:0045123) | 3.56184873 |
| 17 | histone H3-K36 demethylation (GO:0070544) | 3.51111672 |
| 18 | positive regulation of histone deacetylation (GO:0031065) | 3.48806719 |
| 19 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.46912120 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.43194493 |
| 21 | detection of bacterium (GO:0016045) | 3.32729351 |
| 22 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.31130674 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 3.30167615 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 3.28670719 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 3.26690464 |
| 26 | nuclear pore complex assembly (GO:0051292) | 3.25626598 |
| 27 | germinal center formation (GO:0002467) | 3.24181777 |
| 28 | embryonic process involved in female pregnancy (GO:0060136) | 3.22787790 |
| 29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.22168447 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.20597822 |
| 31 | regulation of interferon-alpha production (GO:0032647) | 3.19081214 |
| 32 | leukocyte aggregation (GO:0070486) | 3.18881735 |
| 33 | detection of molecule of bacterial origin (GO:0032490) | 3.18812977 |
| 34 | low-density lipoprotein particle clearance (GO:0034383) | 3.13474014 |
| 35 | NLS-bearing protein import into nucleus (GO:0006607) | 3.13266267 |
| 36 | I-kappaB phosphorylation (GO:0007252) | 3.10556528 |
| 37 | negative regulation of cell killing (GO:0031342) | 3.10382729 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.10382729 |
| 39 | T cell selection (GO:0045058) | 3.08916264 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.08363177 |
| 41 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.06366975 |
| 42 | pre-miRNA processing (GO:0031054) | 3.02551898 |
| 43 | regulation of leukocyte degranulation (GO:0043300) | 2.99979322 |
| 44 | positive T cell selection (GO:0043368) | 2.96987430 |
| 45 | negative T cell selection (GO:0043383) | 2.94277315 |
| 46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.92274603 |
| 47 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.90686904 |
| 48 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.89064463 |
| 49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.87586946 |
| 50 | regulation of cholesterol storage (GO:0010885) | 2.85857673 |
| 51 | macroautophagy (GO:0016236) | 2.84701430 |
| 52 | positive thymic T cell selection (GO:0045059) | 2.83553852 |
| 53 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.82283560 |
| 54 | positive regulation of B cell differentiation (GO:0045579) | 2.82068543 |
| 55 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.81985775 |
| 56 | negative regulation of T cell mediated immunity (GO:0002710) | 2.81370488 |
| 57 | regulation of mast cell degranulation (GO:0043304) | 2.78825263 |
| 58 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.76225908 |
| 59 | T cell migration (GO:0072678) | 2.75690407 |
| 60 | apoptotic cell clearance (GO:0043277) | 2.74991071 |
| 61 | tolerance induction (GO:0002507) | 2.74661069 |
| 62 | response to interleukin-15 (GO:0070672) | 2.73788111 |
| 63 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.72656431 |
| 64 | nuclear pore organization (GO:0006999) | 2.72607284 |
| 65 | detection of biotic stimulus (GO:0009595) | 2.72273099 |
| 66 | response to laminar fluid shear stress (GO:0034616) | 2.72135413 |
| 67 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.70537014 |
| 68 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.70139217 |
| 69 | positive regulation of p38MAPK cascade (GO:1900745) | 2.66714993 |
| 70 | response to host (GO:0075136) | 2.66380380 |
| 71 | response to host defenses (GO:0052200) | 2.66380380 |
| 72 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.66380380 |
| 73 | mannose metabolic process (GO:0006013) | 2.65282625 |
| 74 | regulation of histone H3-K27 methylation (GO:0061085) | 2.64881739 |
| 75 | negative regulation of granulocyte differentiation (GO:0030853) | 2.64281682 |
| 76 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.64102189 |
| 77 | cell adhesion mediated by integrin (GO:0033627) | 2.63788999 |
| 78 | B cell homeostasis (GO:0001782) | 2.63028141 |
| 79 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.62957460 |
| 80 | growth hormone receptor signaling pathway (GO:0060396) | 2.61937197 |
| 81 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.60258889 |
| 82 | response to host immune response (GO:0052572) | 2.60258889 |
| 83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.59016912 |
| 84 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.57445759 |
| 85 | response to type I interferon (GO:0034340) | 2.57440985 |
| 86 | respiratory burst (GO:0045730) | 2.56877966 |
| 87 | type I interferon signaling pathway (GO:0060337) | 2.56510809 |
| 88 | cellular response to type I interferon (GO:0071357) | 2.56510809 |
| 89 | pore complex assembly (GO:0046931) | 2.55416203 |
| 90 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.54223157 |
| 91 | response to muramyl dipeptide (GO:0032495) | 2.53761522 |
| 92 | regulation of T cell tolerance induction (GO:0002664) | 2.51695072 |
| 93 | regulation of necroptotic process (GO:0060544) | 2.51345887 |
| 94 | positive regulation of interferon-beta production (GO:0032728) | 2.50742874 |
| 95 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.50566089 |
| 96 | pinocytosis (GO:0006907) | 2.50421419 |
| 97 | NIK/NF-kappaB signaling (GO:0038061) | 2.50390115 |
| 98 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.49699824 |
| 99 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.48489804 |
| 100 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.47937693 |
| 101 | protein localization to endosome (GO:0036010) | 2.47379552 |
| 102 | granulocyte activation (GO:0036230) | 2.46826036 |
| 103 | neutrophil activation (GO:0042119) | 2.46557645 |
| 104 | regulation of tolerance induction (GO:0002643) | 2.46520578 |
| 105 | defense response to protozoan (GO:0042832) | 2.45885643 |
| 106 | phospholipid homeostasis (GO:0055091) | 2.45542892 |
| 107 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.44392879 |
| 108 | regulation of cholesterol homeostasis (GO:2000188) | 2.44283577 |
| 109 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.44090180 |
| 110 | negative regulation of interleukin-6 production (GO:0032715) | 2.42094674 |
| 111 | natural killer cell mediated immunity (GO:0002228) | 2.41932707 |
| 112 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.41932707 |
| 113 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.41638675 |
| 114 | regulation of regulated secretory pathway (GO:1903305) | 2.40791412 |
| 115 | response to protozoan (GO:0001562) | 2.38650405 |
| 116 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.38560857 |
| 117 | negative regulation of lipid storage (GO:0010888) | 2.38033859 |
| 118 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.37041455 |
| 119 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.36701403 |
| 120 | mitotic sister chromatid cohesion (GO:0007064) | 2.36273389 |
| 121 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.29837890 |
| 122 | lipoprotein transport (GO:0042953) | 2.29295908 |
| 123 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.27763191 |
| 124 | immunoglobulin mediated immune response (GO:0016064) | 2.26059776 |
| 125 | regulation of translational fidelity (GO:0006450) | 2.25703899 |
| 126 | regulation of integrin activation (GO:0033623) | 2.24725177 |
| 127 | regulation of protein polyubiquitination (GO:1902914) | 2.24453359 |
| 128 | positive regulation of protein deacetylation (GO:0090312) | 2.22876542 |
| 129 | regulation of RNA export from nucleus (GO:0046831) | 2.21528139 |
| 130 | B cell receptor signaling pathway (GO:0050853) | 2.20672858 |
| 131 | negative regulation of interleukin-12 production (GO:0032695) | 2.20017652 |
| 132 | response to UV-C (GO:0010225) | 2.19839265 |
| 133 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.18597461 |
| 134 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.18329587 |
| 135 | negative regulation of B cell proliferation (GO:0030889) | 2.16078012 |
| 136 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.15813894 |
| 137 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.15510528 |
| 138 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.15174326 |
| 139 | cortical actin cytoskeleton organization (GO:0030866) | 2.14976161 |
| 140 | cellular response to growth hormone stimulus (GO:0071378) | 2.14344579 |
| 141 | modulation by symbiont of host cellular process (GO:0044068) | 2.13884439 |
| 142 | corticosteroid receptor signaling pathway (GO:0031958) | 2.12901796 |
| 143 | mRNA stabilization (GO:0048255) | 2.12690980 |
| 144 | RNA stabilization (GO:0043489) | 2.12690980 |
| 145 | thymic T cell selection (GO:0045061) | 2.12686501 |
| 146 | negative thymic T cell selection (GO:0045060) | 2.11847712 |
| 147 | myeloid cell activation involved in immune response (GO:0002275) | 2.11797219 |
| 148 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.11209027 |
| 149 | regulation of B cell differentiation (GO:0045577) | 2.10511124 |
| 150 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.10217177 |
| 151 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.09388996 |
| 152 | macrophage activation (GO:0042116) | 2.08894594 |
| 153 | peptidyl-lysine dimethylation (GO:0018027) | 2.08870071 |
| 154 | heterochromatin organization (GO:0070828) | 2.08598722 |
| 155 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.06798461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.78084116 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.38784556 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.58528960 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.36583976 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.00830356 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.90822893 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.82826912 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.75038779 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69913261 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.69564961 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64477720 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.53017952 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.47352993 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.35940566 |
| 15 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.27702133 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.25806687 |
| 17 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.21497268 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.20235445 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.14169221 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.10838205 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.09200294 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.06346529 |
| 23 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.01092903 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.92230889 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.88407768 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 1.88372011 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.82195341 |
| 28 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.79513289 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79434301 |
| 30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78500758 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.76880556 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75958011 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.73015548 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.72233986 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71852031 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68996090 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67815446 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.64423178 |
| 39 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.64224618 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.63911344 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.62130557 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61595160 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.60752471 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60287967 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.58479351 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55681416 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.55536491 |
| 48 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54415224 |
| 49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.52676453 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49304373 |
| 51 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47671839 |
| 52 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41226149 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39081679 |
| 54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37925388 |
| 55 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.28135867 |
| 56 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.27489262 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26189329 |
| 58 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.25914945 |
| 59 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.25129284 |
| 60 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24753368 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24391017 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24226063 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23841625 |
| 64 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.22507602 |
| 65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22413325 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21583124 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21009613 |
| 68 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20200485 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18939521 |
| 70 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18587573 |
| 71 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18348499 |
| 72 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18168197 |
| 73 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17772364 |
| 74 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16500264 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15964606 |
| 76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15319467 |
| 77 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14730397 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13800319 |
| 79 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.13454609 |
| 80 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12872467 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10021260 |
| 82 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.08852783 |
| 83 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08816761 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08230433 |
| 85 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08005450 |
| 86 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07681074 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07576804 |
| 88 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07415861 |
| 89 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.07334360 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06833322 |
| 91 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.05214630 |
| 92 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03323304 |
| 93 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.02082605 |
| 94 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.01927914 |
| 95 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.01590090 |
| 96 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00641825 |
| 97 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00248758 |
| 98 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00080212 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99416486 |
| 100 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.98289362 |
| 101 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.97340134 |
| 102 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97286386 |
| 103 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96936158 |
| 104 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.96689036 |
| 105 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96492315 |
| 106 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96185649 |
| 107 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96065753 |
| 108 | MAF_26560356_Chip-Seq_TH2_Human | 0.95701104 |
| 109 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95657467 |
| 110 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93590523 |
| 111 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93372872 |
| 112 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92155296 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92048485 |
| 114 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.91749806 |
| 115 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.91749806 |
| 116 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.91073301 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91049134 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90848561 |
| 119 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90254696 |
| 120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89707453 |
| 121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89604534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.75919246 |
| 2 | MP0003303_peritoneal_inflammation | 3.48915591 |
| 3 | MP0003300_gastrointestinal_ulcer | 3.10076902 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 2.95257277 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 2.78259400 |
| 6 | MP0005076_abnormal_cell_differentiation | 2.64198571 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.62624807 |
| 8 | MP0003724_increased_susceptibility_to | 2.56941746 |
| 9 | MP0010307_abnormal_tumor_latency | 2.51939639 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.47615160 |
| 11 | MP0005451_abnormal_body_composition | 2.37173263 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.35088114 |
| 13 | MP0003436_decreased_susceptibility_to | 2.34113970 |
| 14 | MP0009840_abnormal_foam_cell | 2.04070227 |
| 15 | MP0004947_skin_inflammation | 2.03533632 |
| 16 | MP0004510_myositis | 1.96342269 |
| 17 | MP0009278_abnormal_bone_marrow | 1.93717938 |
| 18 | MP0002009_preneoplasia | 1.92315338 |
| 19 | MP0003566_abnormal_cell_adhesion | 1.91214930 |
| 20 | MP0008260_abnormal_autophagy | 1.87397323 |
| 21 | MP0001800_abnormal_humoral_immune | 1.86488113 |
| 22 | MP0002166_altered_tumor_susceptibility | 1.86335814 |
| 23 | MP0005464_abnormal_platelet_physiology | 1.83348528 |
| 24 | MP0003828_pulmonary_edema | 1.80222837 |
| 25 | MP0001790_abnormal_immune_system | 1.77202452 |
| 26 | MP0005387_immune_system_phenotype | 1.77202452 |
| 27 | MP0002419_abnormal_innate_immunity | 1.72680527 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.69862435 |
| 29 | MP0000685_abnormal_immune_system | 1.68681982 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.63880734 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.61626234 |
| 32 | MP0006082_CNS_inflammation | 1.58293146 |
| 33 | MP0003091_abnormal_cell_migration | 1.56200184 |
| 34 | MP0004381_abnormal_hair_follicle | 1.52388322 |
| 35 | MP0002723_abnormal_immune_serum | 1.50225339 |
| 36 | MP0005360_urolithiasis | 1.47094010 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.47037555 |
| 38 | MP0002006_tumorigenesis | 1.45084653 |
| 39 | MP0003252_abnormal_bile_duct | 1.44389551 |
| 40 | MP0008961_abnormal_basal_metabolism | 1.43504896 |
| 41 | MP0004185_abnormal_adipocyte_glucose | 1.42000692 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.38221792 |
| 43 | MP0001819_abnormal_immune_cell | 1.38039818 |
| 44 | MP0002398_abnormal_bone_marrow | 1.37287655 |
| 45 | MP0005025_abnormal_response_to | 1.36707828 |
| 46 | MP0003448_altered_tumor_morphology | 1.35977010 |
| 47 | MP0003045_fibrosis | 1.35877843 |
| 48 | MP0005023_abnormal_wound_healing | 1.35417455 |
| 49 | MP0000733_abnormal_muscle_development | 1.31245495 |
| 50 | MP0005409_darkened_coat_color | 1.30588868 |
| 51 | MP0008057_abnormal_DNA_replication | 1.28790604 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 1.27852977 |
| 53 | MP0004264_abnormal_extraembryonic_tissu | 1.27794864 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.27063576 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.27063576 |
| 56 | MP0005365_abnormal_bile_salt | 1.26758985 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.25158122 |
| 58 | MP0001851_eye_inflammation | 1.23185590 |
| 59 | MP0002139_abnormal_hepatobiliary_system | 1.22527895 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.22416782 |
| 61 | MP0002405_respiratory_system_inflammati | 1.22329506 |
| 62 | MP0000716_abnormal_immune_system | 1.21676007 |
| 63 | MP0000609_abnormal_liver_physiology | 1.21665600 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.20830716 |
| 65 | MP0000371_diluted_coat_color | 1.20105314 |
| 66 | MP0005671_abnormal_response_to | 1.19830664 |
| 67 | MP0009785_altered_susceptibility_to | 1.17425305 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.17267877 |
| 69 | MP0004130_abnormal_muscle_cell | 1.16850089 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 1.16657532 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.16207887 |
| 72 | MP0002722_abnormal_immune_system | 1.16079434 |
| 73 | MP0010155_abnormal_intestine_physiology | 1.15774836 |
| 74 | MP0002877_abnormal_melanocyte_morpholog | 1.15261033 |
| 75 | MP0005083_abnormal_biliary_tract | 1.11363074 |
| 76 | MP0000604_amyloidosis | 1.07149903 |
| 77 | MP0010329_abnormal_lipoprotein_level | 1.03339892 |
| 78 | MP0001915_intracranial_hemorrhage | 1.03284690 |
| 79 | MP0000703_abnormal_thymus_morphology | 1.02731610 |
| 80 | MP0002429_abnormal_blood_cell | 1.02685707 |
| 81 | MP0001849_ear_inflammation | 1.00926638 |
| 82 | MP0001873_stomach_inflammation | 1.00788360 |
| 83 | MP0004883_abnormal_blood_vessel | 1.00748224 |
| 84 | MP0003866_abnormal_defecation | 1.00526389 |
| 85 | MP0002998_abnormal_bone_remodeling | 0.99859838 |
| 86 | MP0001853_heart_inflammation | 0.99518010 |
| 87 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99283724 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.96050265 |
| 89 | MP0002796_impaired_skin_barrier | 0.95988760 |
| 90 | MP0008469_abnormal_protein_level | 0.95547952 |
| 91 | MP0000858_altered_metastatic_potential | 0.95483198 |
| 92 | MP0000015_abnormal_ear_pigmentation | 0.91463292 |
| 93 | MP0000598_abnormal_liver_morphology | 0.91266990 |
| 94 | MP0004233_abnormal_muscle_weight | 0.90100825 |
| 95 | MP0002928_abnormal_bile_duct | 0.89245293 |
| 96 | MP0005257_abnormal_intraocular_pressure | 0.88316078 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.87522566 |
| 98 | MP0003763_abnormal_thymus_physiology | 0.86071103 |
| 99 | MP0002254_reproductive_system_inflammat | 0.84503493 |
| 100 | MP0003075_altered_response_to | 0.83622475 |
| 101 | MP0005164_abnormal_response_to | 0.83491000 |
| 102 | MP0000465_gastrointestinal_hemorrhage | 0.82581078 |
| 103 | MP0005310_abnormal_salivary_gland | 0.82079274 |
| 104 | MP0002086_abnormal_extraembryonic_tissu | 0.80103362 |
| 105 | MP0005166_decreased_susceptibility_to | 0.79884961 |
| 106 | MP0003690_abnormal_glial_cell | 0.79486758 |
| 107 | MP0005085_abnormal_gallbladder_physiolo | 0.77887062 |
| 108 | MP0005621_abnormal_cell_physiology | 0.76993123 |
| 109 | MP0001348_abnormal_lacrimal_gland | 0.76312830 |
| 110 | MP0009763_increased_sensitivity_to | 0.76307199 |
| 111 | MP0004197_abnormal_fetal_growth/weight/ | 0.75249868 |
| 112 | MP0009333_abnormal_splenocyte_physiolog | 0.75059366 |
| 113 | MP0000490_abnormal_crypts_of | 0.73601335 |
| 114 | MP0002088_abnormal_embryonic_growth/wei | 0.73577040 |
| 115 | MP0009115_abnormal_fat_cell | 0.72999534 |
| 116 | MP0002148_abnormal_hypersensitivity_rea | 0.72963590 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.72919073 |
| 118 | MP0000767_abnormal_smooth_muscle | 0.72598302 |
| 119 | MP0003984_embryonic_growth_retardation | 0.71740136 |
| 120 | MP0002933_joint_inflammation | 0.71595330 |
| 121 | MP0001216_abnormal_epidermal_layer | 0.71438325 |
| 122 | MP0003795_abnormal_bone_structure | 0.69932636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.22444371 |
| 2 | Myocardial infarction (HP:0001658) | 3.06110519 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 2.99293208 |
| 4 | Orchitis (HP:0100796) | 2.93648177 |
| 5 | Cerebral aneurysm (HP:0004944) | 2.93315915 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 2.85436479 |
| 7 | Gastrointestinal infarctions (HP:0005244) | 2.83901908 |
| 8 | Recurrent viral infections (HP:0004429) | 2.82217524 |
| 9 | Abnormality of the fingertips (HP:0001211) | 2.80865038 |
| 10 | Recurrent abscess formation (HP:0002722) | 2.79096990 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.75463887 |
| 12 | Optic neuritis (HP:0100653) | 2.73099338 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 2.73099338 |
| 14 | Increased IgE level (HP:0003212) | 2.72640313 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 2.70349001 |
| 16 | Spontaneous hematomas (HP:0007420) | 2.63264912 |
| 17 | Hematochezia (HP:0002573) | 2.63087174 |
| 18 | Recurrent fungal infections (HP:0002841) | 2.61694966 |
| 19 | Vasculitis (HP:0002633) | 2.45382351 |
| 20 | Meningitis (HP:0001287) | 2.44947810 |
| 21 | Colitis (HP:0002583) | 2.44370659 |
| 22 | Macroorchidism (HP:0000053) | 2.40311754 |
| 23 | Pustule (HP:0200039) | 2.38219481 |
| 24 | Slow saccadic eye movements (HP:0000514) | 2.34474538 |
| 25 | Periodontitis (HP:0000704) | 2.33113182 |
| 26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.31401074 |
| 27 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.31254016 |
| 28 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29701970 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29701970 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29701970 |
| 31 | Broad face (HP:0000283) | 2.29454228 |
| 32 | Mucopolysacchariduria (HP:0008155) | 2.29065691 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.29065691 |
| 34 | Hyperacusis (HP:0010780) | 2.27873344 |
| 35 | Subacute progressive viral hepatitis (HP:0006572) | 2.22182495 |
| 36 | Urethral obstruction (HP:0000796) | 2.19530524 |
| 37 | Heterotopia (HP:0002282) | 2.17266294 |
| 38 | Cellulitis (HP:0100658) | 2.17255120 |
| 39 | Frequent falls (HP:0002359) | 2.16076127 |
| 40 | Dysostosis multiplex (HP:0000943) | 2.15746901 |
| 41 | Prolonged bleeding time (HP:0003010) | 2.13783123 |
| 42 | Osteolytic defects of the hand bones (HP:0009699) | 2.13082243 |
| 43 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.13082243 |
| 44 | Obstructive lung disease (HP:0006536) | 2.12974831 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12974831 |
| 46 | Increased density of long bones (HP:0006392) | 2.12656529 |
| 47 | Gingival bleeding (HP:0000225) | 2.11373982 |
| 48 | Epistaxis (HP:0000421) | 2.09736146 |
| 49 | Thin bony cortex (HP:0002753) | 2.08658895 |
| 50 | Disinhibition (HP:0000734) | 2.07573102 |
| 51 | Flat acetabular roof (HP:0003180) | 2.07517841 |
| 52 | Arterial thrombosis (HP:0004420) | 2.04798364 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.04570845 |
| 54 | Aortic aneurysm (HP:0004942) | 2.02767295 |
| 55 | Fatigue (HP:0012378) | 2.01780425 |
| 56 | Recurrent skin infections (HP:0001581) | 2.01705148 |
| 57 | Recurrent cutaneous fungal infections (HP:0011370) | 2.00175067 |
| 58 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.00175067 |
| 59 | Mitral valve prolapse (HP:0001634) | 1.99745778 |
| 60 | Inflammation of the large intestine (HP:0002037) | 1.99572283 |
| 61 | Upper motor neuron abnormality (HP:0002127) | 1.98163673 |
| 62 | Gastrointestinal inflammation (HP:0004386) | 1.96564451 |
| 63 | Global brain atrophy (HP:0002283) | 1.96302627 |
| 64 | Cervical subluxation (HP:0003308) | 1.95401004 |
| 65 | Urticaria (HP:0001025) | 1.95361021 |
| 66 | Loss of speech (HP:0002371) | 1.95091740 |
| 67 | Absent frontal sinuses (HP:0002688) | 1.94465078 |
| 68 | Mediastinal lymphadenopathy (HP:0100721) | 1.93404481 |
| 69 | Interstitial pulmonary disease (HP:0006530) | 1.93350122 |
| 70 | Keratoconjunctivitis sicca (HP:0001097) | 1.93079158 |
| 71 | Viral hepatitis (HP:0006562) | 1.91215061 |
| 72 | Gingivitis (HP:0000230) | 1.90189676 |
| 73 | Obstructive sleep apnea (HP:0002870) | 1.90054933 |
| 74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.89873682 |
| 75 | Axonal loss (HP:0003447) | 1.89857145 |
| 76 | Abnormality of the thoracic spine (HP:0100711) | 1.89595371 |
| 77 | Complement deficiency (HP:0004431) | 1.89444430 |
| 78 | Dislocated radial head (HP:0003083) | 1.89234205 |
| 79 | Pulmonary infiltrates (HP:0002113) | 1.88861689 |
| 80 | Abnormal platelet function (HP:0011869) | 1.88040412 |
| 81 | Impaired platelet aggregation (HP:0003540) | 1.88040412 |
| 82 | Hemoptysis (HP:0002105) | 1.87793673 |
| 83 | Abnormality of macrophages (HP:0004311) | 1.87643724 |
| 84 | Spastic diplegia (HP:0001264) | 1.86417749 |
| 85 | Aneurysm (HP:0002617) | 1.85097672 |
| 86 | Upper limb amyotrophy (HP:0009129) | 1.84949320 |
| 87 | Distal upper limb amyotrophy (HP:0007149) | 1.84949320 |
| 88 | Ulnar bowing (HP:0003031) | 1.83514863 |
| 89 | Encephalitis (HP:0002383) | 1.82620277 |
| 90 | Spinal cord lesions (HP:0100561) | 1.82368268 |
| 91 | Syringomyelia (HP:0003396) | 1.82368268 |
| 92 | Increased CSF protein (HP:0002922) | 1.82332822 |
| 93 | Hand muscle atrophy (HP:0009130) | 1.82096187 |
| 94 | Esophageal varix (HP:0002040) | 1.80742276 |
| 95 | Abnormal platelet volume (HP:0011876) | 1.79955784 |
| 96 | Gastrointestinal stroma tumor (HP:0100723) | 1.79331214 |
| 97 | Deep venous thrombosis (HP:0002625) | 1.78649733 |
| 98 | Thoracic kyphosis (HP:0002942) | 1.78480662 |
| 99 | Persistence of primary teeth (HP:0006335) | 1.77287633 |
| 100 | Abnormality of T cells (HP:0002843) | 1.77264100 |
| 101 | Stomatitis (HP:0010280) | 1.77116847 |
| 102 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76804992 |
| 103 | Cortical dysplasia (HP:0002539) | 1.76449150 |
| 104 | Osteomyelitis (HP:0002754) | 1.76359215 |
| 105 | Pseudobulbar signs (HP:0002200) | 1.76207138 |
| 106 | T lymphocytopenia (HP:0005403) | 1.76164393 |
| 107 | Increased mean platelet volume (HP:0011877) | 1.75735689 |
| 108 | Striae distensae (HP:0001065) | 1.75389798 |
| 109 | Sparse lateral eyebrow (HP:0005338) | 1.75128164 |
| 110 | Tetraparesis (HP:0002273) | 1.73639050 |
| 111 | Neonatal hypoglycemia (HP:0001998) | 1.72952073 |
| 112 | Coarse hair (HP:0002208) | 1.72866065 |
| 113 | Chronic otitis media (HP:0000389) | 1.72527037 |
| 114 | Narrow palate (HP:0000189) | 1.72183027 |
| 115 | Amyloidosis (HP:0011034) | 1.71900696 |
| 116 | Dilatation of the ascending aorta (HP:0005111) | 1.70462101 |
| 117 | Spondylolisthesis (HP:0003302) | 1.70276080 |
| 118 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.69562109 |
| 119 | Joint hemorrhage (HP:0005261) | 1.68676604 |
| 120 | Abnormality of glycolipid metabolism (HP:0010969) | 1.68131359 |
| 121 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.68131359 |
| 122 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.68131359 |
| 123 | Lymphopenia (HP:0001888) | 1.68002790 |
| 124 | Volvulus (HP:0002580) | 1.67770335 |
| 125 | Distal lower limb amyotrophy (HP:0008944) | 1.67770033 |
| 126 | Dysmetric saccades (HP:0000641) | 1.67658580 |
| 127 | Abnormality of the radial head (HP:0003995) | 1.67549926 |
| 128 | Personality changes (HP:0000751) | 1.67181660 |
| 129 | Myositis (HP:0100614) | 1.67074881 |
| 130 | Leukocytosis (HP:0001974) | 1.66410194 |
| 131 | Abnormality of T cell number (HP:0011839) | 1.65554200 |
| 132 | Cutaneous melanoma (HP:0012056) | 1.65380781 |
| 133 | Vertebral compression fractures (HP:0002953) | 1.64983849 |
| 134 | Keratoconjunctivitis (HP:0001096) | 1.64977764 |
| 135 | Abnormality of the common coagulation pathway (HP:0010990) | 1.64919905 |
| 136 | Papilloma (HP:0012740) | 1.64465276 |
| 137 | Verrucae (HP:0200043) | 1.64465276 |
| 138 | Elfin facies (HP:0004428) | 1.64366464 |
| 139 | Cheilitis (HP:0100825) | 1.63905504 |
| 140 | Skin ulcer (HP:0200042) | 1.63664393 |
| 141 | Chest pain (HP:0100749) | 1.62905840 |
| 142 | Vacuolated lymphocytes (HP:0001922) | 1.62689702 |
| 143 | Mitral stenosis (HP:0001718) | 1.62000492 |
| 144 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.61836958 |
| 145 | Prominent nose (HP:0000448) | 1.61308036 |
| 146 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.60452488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.96082543 |
| 2 | CDK12 | 3.59526071 |
| 3 | TRIB3 | 2.89885810 |
| 4 | ERN1 | 2.57421237 |
| 5 | PKN2 | 2.55045521 |
| 6 | MAP3K10 | 2.45011967 |
| 7 | CAMK1D | 2.33149473 |
| 8 | MAP4K1 | 2.32852843 |
| 9 | EEF2K | 2.32773254 |
| 10 | TYK2 | 2.14756115 |
| 11 | TTN | 2.08599922 |
| 12 | SMG1 | 2.06173800 |
| 13 | SIK1 | 1.98133810 |
| 14 | LATS1 | 1.93881763 |
| 15 | RIPK1 | 1.93461598 |
| 16 | JAK1 | 1.87134419 |
| 17 | CAMK1G | 1.86219976 |
| 18 | TAOK3 | 1.81414754 |
| 19 | STK10 | 1.81155051 |
| 20 | IRAK4 | 1.76902490 |
| 21 | FGFR4 | 1.74645105 |
| 22 | PTK6 | 1.73300200 |
| 23 | TBK1 | 1.57660044 |
| 24 | FGFR3 | 1.56060827 |
| 25 | MAP3K14 | 1.53735237 |
| 26 | JAK3 | 1.50356740 |
| 27 | TGFBR2 | 1.44204931 |
| 28 | BRD4 | 1.40121057 |
| 29 | SCYL2 | 1.38042691 |
| 30 | SIK2 | 1.37150817 |
| 31 | ALK | 1.30466895 |
| 32 | CDK6 | 1.29706410 |
| 33 | BMX | 1.26788364 |
| 34 | HCK | 1.24048698 |
| 35 | TAOK2 | 1.24017864 |
| 36 | SIK3 | 1.21857039 |
| 37 | GRK6 | 1.18494874 |
| 38 | MAP3K1 | 1.17404048 |
| 39 | CSF1R | 1.17309968 |
| 40 | EPHB1 | 1.14520666 |
| 41 | LRRK2 | 1.14113145 |
| 42 | * MTOR | 1.13322684 |
| 43 | JAK2 | 1.12390855 |
| 44 | STK3 | 1.12280151 |
| 45 | ICK | 1.11773742 |
| 46 | CHUK | 1.10307200 |
| 47 | ZAP70 | 1.09933229 |
| 48 | RPS6KA4 | 1.09617659 |
| 49 | RIPK4 | 1.08705944 |
| 50 | MARK2 | 1.07713136 |
| 51 | IKBKE | 1.06610612 |
| 52 | MAP2K3 | 1.06575530 |
| 53 | PDGFRB | 1.05948015 |
| 54 | CDC42BPA | 1.05235266 |
| 55 | MAP3K13 | 1.03437592 |
| 56 | KIT | 1.01985368 |
| 57 | TXK | 1.00979323 |
| 58 | IRAK2 | 1.00118225 |
| 59 | ITK | 0.97407376 |
| 60 | NEK2 | 0.96565770 |
| 61 | IKBKB | 0.96180024 |
| 62 | PDGFRA | 0.94751908 |
| 63 | PIM1 | 0.93603221 |
| 64 | YES1 | 0.91476193 |
| 65 | SGK3 | 0.90915894 |
| 66 | TAOK1 | 0.90560214 |
| 67 | MAP3K7 | 0.89468175 |
| 68 | TRPM7 | 0.88013968 |
| 69 | DMPK | 0.86875095 |
| 70 | BMPR2 | 0.86768715 |
| 71 | CSK | 0.86203524 |
| 72 | CDK4 | 0.83892965 |
| 73 | FGR | 0.80716622 |
| 74 | TNK2 | 0.80522541 |
| 75 | PRKD2 | 0.80429909 |
| 76 | NEK9 | 0.79736934 |
| 77 | MARK3 | 0.79003814 |
| 78 | IRAK1 | 0.78281411 |
| 79 | EPHA3 | 0.76537583 |
| 80 | RET | 0.75295761 |
| 81 | SYK | 0.72130385 |
| 82 | IRAK3 | 0.69036700 |
| 83 | EGFR | 0.68490028 |
| 84 | BTK | 0.68280133 |
| 85 | MAP3K11 | 0.67632594 |
| 86 | MAP3K8 | 0.67003450 |
| 87 | STK4 | 0.66740844 |
| 88 | MAPK12 | 0.66154353 |
| 89 | LCK | 0.64498796 |
| 90 | PRKCH | 0.64477455 |
| 91 | MAP3K6 | 0.63590242 |
| 92 | RPS6KC1 | 0.63449590 |
| 93 | RPS6KL1 | 0.63449590 |
| 94 | FLT3 | 0.61904682 |
| 95 | PDK1 | 0.60830998 |
| 96 | RPS6KA2 | 0.58682165 |
| 97 | CDK9 | 0.57941137 |
| 98 | FRK | 0.55707603 |
| 99 | KSR2 | 0.55695498 |
| 100 | SGK2 | 0.55381526 |
| 101 | PAK2 | 0.55053027 |
| 102 | NLK | 0.54783105 |
| 103 | MAP3K2 | 0.54707585 |
| 104 | AKT3 | 0.53181034 |
| 105 | PTK2 | 0.52964278 |
| 106 | TEC | 0.52160013 |
| 107 | MAPK11 | 0.49982273 |
| 108 | MATK | 0.49310852 |
| 109 | WNK1 | 0.49268563 |
| 110 | RPS6KA6 | 0.48217078 |
| 111 | MELK | 0.48127036 |
| 112 | NME2 | 0.47013003 |
| 113 | PAK4 | 0.46005924 |
| 114 | ABL1 | 0.44723750 |
| 115 | MAP3K9 | 0.44367091 |
| 116 | BLK | 0.43435043 |
| 117 | PRKAA2 | 0.43078916 |
| 118 | CAMKK1 | 0.42495010 |
| 119 | HIPK2 | 0.41026421 |
| 120 | MAPK7 | 0.39586009 |
| 121 | PDPK1 | 0.38157238 |
| 122 | FES | 0.37787799 |
| 123 | MAP3K3 | 0.36433529 |
| 124 | MAP3K5 | 0.35884892 |
| 125 | INSR | 0.33276933 |
| 126 | DYRK1B | 0.32964159 |
| 127 | ERBB2 | 0.32777078 |
| 128 | ERBB4 | 0.32688022 |
| 129 | ATR | 0.32450186 |
| 130 | LYN | 0.31334655 |
| 131 | FGFR2 | 0.30304406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.20437085 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98241670 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96596590 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.95654516 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95086282 |
| 6 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.78624420 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.66674465 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.58570340 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.57321589 |
| 10 | Lysine degradation_Homo sapiens_hsa00310 | 1.55306322 |
| 11 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.49069019 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43054113 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.42971005 |
| 14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42288479 |
| 15 | Insulin resistance_Homo sapiens_hsa04931 | 1.35278568 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.32108372 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31546866 |
| 18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.30729670 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.29034239 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28505351 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26703007 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.26550390 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.26351863 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.24873712 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.23978111 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.22305638 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20984253 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20690416 |
| 29 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.20123149 |
| 30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.19017550 |
| 31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.18412071 |
| 32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.17201624 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.15318359 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.14707050 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.13310719 |
| 36 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.13299775 |
| 37 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.12883476 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.12166377 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.11749048 |
| 40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11198299 |
| 41 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.10226922 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.06235225 |
| 43 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.05055863 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03881190 |
| 45 | Thyroid cancer_Homo sapiens_hsa05216 | 1.01959769 |
| 46 | Bladder cancer_Homo sapiens_hsa05219 | 1.01917104 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01630646 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 1.01134422 |
| 49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.00056281 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99598887 |
| 51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.97443947 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96774934 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96629385 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 0.96433340 |
| 55 | Glioma_Homo sapiens_hsa05214 | 0.95691186 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94976187 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94768839 |
| 58 | Malaria_Homo sapiens_hsa05144 | 0.94257755 |
| 59 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92132391 |
| 60 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.90885576 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.90265903 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90203007 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90072758 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.89145242 |
| 65 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.88153601 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88081967 |
| 67 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87261497 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86774471 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.85353368 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 0.84754415 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83950081 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.83572627 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82862922 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82535107 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.82508619 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.81745866 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80089400 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79217348 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78083452 |
| 80 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77956453 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76711638 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76032170 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.75512660 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74877900 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74522609 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74411942 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74182918 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73901525 |
| 89 | Shigellosis_Homo sapiens_hsa05131 | 0.73435648 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72496358 |
| 91 | Prostate cancer_Homo sapiens_hsa05215 | 0.70718837 |
| 92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70227294 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.70118172 |
| 94 | Focal adhesion_Homo sapiens_hsa04510 | 0.70062576 |
| 95 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69403209 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67284205 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66019314 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66014489 |
| 99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65531728 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64844260 |
| 101 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.64300187 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63255171 |
| 103 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62826931 |
| 104 | ABC transporters_Homo sapiens_hsa02010 | 0.62142879 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.62095785 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61727107 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60975340 |
| 108 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60153770 |
| 109 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60042898 |
| 110 | Asthma_Homo sapiens_hsa05310 | 0.59942233 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59467611 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59339302 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57657789 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56705688 |
| 115 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54873060 |
| 116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54713629 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54472187 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.51502399 |
| 119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48429633 |

